☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
InflaRx
InflaRx Report EMA’s Validation of MAA for Vilobelimab to Treat Critically Ill COVID-19 Patients
August 30, 2023
InflaRx Receives the US FDA’s EUA for Gohibic (vilobelimab) to Treat COVID-19
April 5, 2023
InflaRx Reports Results of Vilobelimab in the P-III Part of P-II/III (PANAMO) Study for the Treatment of Severe COVID-19
April 1, 2022
PharmaShots Weekly Snapshots (May 10 - 14, 2021)
May 14, 2021
Insights+: COVID-19 Healthcare News Monthly Updates - June 2020
June 30, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.